REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Celalcivar S.A. (Ecuador)

Main Activities: Blood and Organ Banks
Full name: Celalcivar S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Celalcivar S.A. is a company in Ecuador, with a head office in Guayaquil. It operates in the Blood and Organ Banks sector. Celalcivar S.A. was incorporated on December 16, 2011. There are currently 4 (2023) people employed by Celalcivar S.A.. From the latest financial highlights, Celalcivar S.A. reported a net sales revenue drop of 70.88% in 2022. There was a total negative growth of 54.95% in Celalcivar S.A.’s total assets over the same period. The enterprise’s net profit margin increased by 6.3% in 2022.

Headquarters
Azuay 601, Torre Medica 5 Bldg. , Floor 301
Guayaquil; Guayas;

Contact Details: Purchase the Celalcivar S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Celalcivar S.A. report to view the information.
Outstanding Shares:
Purchase the Celalcivar S.A. report to view the information.
Registered Capital:
Purchase the Celalcivar S.A. report to view the information.
Incorporation Date:
December 16, 2011
Key Executives
Purchase this report to view the information.
Executive President
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
72.31%
Purchase this report to view the information.
20%
Purchase this report to view the information.
7.69%
Company Performance
Financial values in the chart are available after Celalcivar S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-70.88%▼
Total operating revenue
-70.88%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
62.12%▲
Total assets
-54.95%▼
Total equity
119.22%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
6.3%▲
Return on Equity (ROE)
-18.88%▼
Quick Ratio
3.56%▲
Cash Ratio
2.78%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo